Unexpected Mutations by CRISPR-Cas9 CTG Repeat Excision in Myotonic Dystrophy and Use of CRISPR Interference as an Alternative Approach

Myotonic dystrophy type 1 is the most common type of adult-onset muscular dystrophy. This is an autosomal dominant disorder and caused by the expansion of the CTG repeat in the 3′ untranslated region of the dystrophia myotonica protein kinase (DMPK) gene. Messenger RNAs containing these expanded rep...

Full description

Bibliographic Details
Main Authors: Miki Ikeda, Mariko Taniguchi-Ikeda, Takema Kato, Yasuko Shinkai, Sonoko Tanaka, Hiroki Hagiwara, Naomichi Sasaki, Toshihiro Masaki, Kiichiro Matsumura, Masahiro Sonoo, Hiroki Kurahashi, Fumiaki Saito
Format: Article
Language:English
Published: Elsevier 2020-09-01
Series:Molecular Therapy: Methods & Clinical Development
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S232905012030111X
_version_ 1818973721221660672
author Miki Ikeda
Mariko Taniguchi-Ikeda
Takema Kato
Yasuko Shinkai
Sonoko Tanaka
Hiroki Hagiwara
Naomichi Sasaki
Toshihiro Masaki
Kiichiro Matsumura
Masahiro Sonoo
Hiroki Kurahashi
Fumiaki Saito
author_facet Miki Ikeda
Mariko Taniguchi-Ikeda
Takema Kato
Yasuko Shinkai
Sonoko Tanaka
Hiroki Hagiwara
Naomichi Sasaki
Toshihiro Masaki
Kiichiro Matsumura
Masahiro Sonoo
Hiroki Kurahashi
Fumiaki Saito
author_sort Miki Ikeda
collection DOAJ
description Myotonic dystrophy type 1 is the most common type of adult-onset muscular dystrophy. This is an autosomal dominant disorder and caused by the expansion of the CTG repeat in the 3′ untranslated region of the dystrophia myotonica protein kinase (DMPK) gene. Messenger RNAs containing these expanded repeats form aggregates as nuclear RNA foci. Then, RNA binding proteins, including muscleblind-like 1, are sequestered to the RNA foci, leading to systemic abnormal RNA splicing. In this study, we used CRISPR-Cas9 genome editing to excise this CTG repeat. Dual cleavage at the 5′ and 3′ regions of the repeat using a conventional Cas9 nuclease and a double nicking with Cas9 nickase successfully excised the CTG repeat. Subsequently, the formation of the RNA foci was markedly reduced in patient-derived fibroblasts. However, contrary to expectations, a considerable amount of off-target digestions and on-target genomic rearrangements were observed using high-throughput genome-wide translocation sequencing. Finally, the suppression of DMPK transcripts using CRISPR interference significantly decreased the intensity of RNA foci. Our results indicate that close attention should be paid to the unintended mutations when double-strand breaks are generated by CRISPR-Cas9 for therapeutic purposes. Alternative approaches independent of double-strand breaks, including CRISPR interference, may be considered.
first_indexed 2024-12-20T15:28:40Z
format Article
id doaj.art-023d7e99a665465ca9bfb584a02b1aa6
institution Directory Open Access Journal
issn 2329-0501
language English
last_indexed 2024-12-20T15:28:40Z
publishDate 2020-09-01
publisher Elsevier
record_format Article
series Molecular Therapy: Methods & Clinical Development
spelling doaj.art-023d7e99a665465ca9bfb584a02b1aa62022-12-21T19:35:43ZengElsevierMolecular Therapy: Methods & Clinical Development2329-05012020-09-0118131144Unexpected Mutations by CRISPR-Cas9 CTG Repeat Excision in Myotonic Dystrophy and Use of CRISPR Interference as an Alternative ApproachMiki Ikeda0Mariko Taniguchi-Ikeda1Takema Kato2Yasuko Shinkai3Sonoko Tanaka4Hiroki Hagiwara5Naomichi Sasaki6Toshihiro Masaki7Kiichiro Matsumura8Masahiro Sonoo9Hiroki Kurahashi10Fumiaki Saito11Department of Neurology, School of Medicine, Teikyo University, Tokyo 1738606, JapanDepartment of Clinical Genetics, Fujita Health University Hospital, Aichi 4701192, Japan; Division of Molecular Genetics, Institute for Comprehensive Medical Science, Fujita Health University, Aichi 4701192, JapanDivision of Molecular Genetics, Institute for Comprehensive Medical Science, Fujita Health University, Aichi 4701192, JapanDivision of Molecular Genetics, Institute for Comprehensive Medical Science, Fujita Health University, Aichi 4701192, JapanDepartment of Neurology, School of Medicine, Teikyo University, Tokyo 1738606, JapanDepartment of Medical Science, Teikyo University of Science, Uenohara Campus, Yamanashi 4090193, JapanDepartment of Medical Science, Teikyo University of Science, Senju Campus, Tokyo 1200045, JapanDepartment of Medical Science, Teikyo University of Science, Senju Campus, Tokyo 1200045, JapanDepartment of Neurology, School of Medicine, Teikyo University, Tokyo 1738606, JapanDepartment of Neurology, School of Medicine, Teikyo University, Tokyo 1738606, JapanDivision of Molecular Genetics, Institute for Comprehensive Medical Science, Fujita Health University, Aichi 4701192, JapanDepartment of Neurology, School of Medicine, Teikyo University, Tokyo 1738606, Japan; Corresponding author: Fumiaki Saito, Department of Neurology, School of Medicine, Teikyo University, 2-11-1 Kaga, Itabashi-ku, Tokyo 1738606.Myotonic dystrophy type 1 is the most common type of adult-onset muscular dystrophy. This is an autosomal dominant disorder and caused by the expansion of the CTG repeat in the 3′ untranslated region of the dystrophia myotonica protein kinase (DMPK) gene. Messenger RNAs containing these expanded repeats form aggregates as nuclear RNA foci. Then, RNA binding proteins, including muscleblind-like 1, are sequestered to the RNA foci, leading to systemic abnormal RNA splicing. In this study, we used CRISPR-Cas9 genome editing to excise this CTG repeat. Dual cleavage at the 5′ and 3′ regions of the repeat using a conventional Cas9 nuclease and a double nicking with Cas9 nickase successfully excised the CTG repeat. Subsequently, the formation of the RNA foci was markedly reduced in patient-derived fibroblasts. However, contrary to expectations, a considerable amount of off-target digestions and on-target genomic rearrangements were observed using high-throughput genome-wide translocation sequencing. Finally, the suppression of DMPK transcripts using CRISPR interference significantly decreased the intensity of RNA foci. Our results indicate that close attention should be paid to the unintended mutations when double-strand breaks are generated by CRISPR-Cas9 for therapeutic purposes. Alternative approaches independent of double-strand breaks, including CRISPR interference, may be considered.http://www.sciencedirect.com/science/article/pii/S232905012030111XCRISPR-Cas9genome editingmyotonic dystrophyDMPKRNA focioff-target
spellingShingle Miki Ikeda
Mariko Taniguchi-Ikeda
Takema Kato
Yasuko Shinkai
Sonoko Tanaka
Hiroki Hagiwara
Naomichi Sasaki
Toshihiro Masaki
Kiichiro Matsumura
Masahiro Sonoo
Hiroki Kurahashi
Fumiaki Saito
Unexpected Mutations by CRISPR-Cas9 CTG Repeat Excision in Myotonic Dystrophy and Use of CRISPR Interference as an Alternative Approach
Molecular Therapy: Methods & Clinical Development
CRISPR-Cas9
genome editing
myotonic dystrophy
DMPK
RNA foci
off-target
title Unexpected Mutations by CRISPR-Cas9 CTG Repeat Excision in Myotonic Dystrophy and Use of CRISPR Interference as an Alternative Approach
title_full Unexpected Mutations by CRISPR-Cas9 CTG Repeat Excision in Myotonic Dystrophy and Use of CRISPR Interference as an Alternative Approach
title_fullStr Unexpected Mutations by CRISPR-Cas9 CTG Repeat Excision in Myotonic Dystrophy and Use of CRISPR Interference as an Alternative Approach
title_full_unstemmed Unexpected Mutations by CRISPR-Cas9 CTG Repeat Excision in Myotonic Dystrophy and Use of CRISPR Interference as an Alternative Approach
title_short Unexpected Mutations by CRISPR-Cas9 CTG Repeat Excision in Myotonic Dystrophy and Use of CRISPR Interference as an Alternative Approach
title_sort unexpected mutations by crispr cas9 ctg repeat excision in myotonic dystrophy and use of crispr interference as an alternative approach
topic CRISPR-Cas9
genome editing
myotonic dystrophy
DMPK
RNA foci
off-target
url http://www.sciencedirect.com/science/article/pii/S232905012030111X
work_keys_str_mv AT mikiikeda unexpectedmutationsbycrisprcas9ctgrepeatexcisioninmyotonicdystrophyanduseofcrisprinterferenceasanalternativeapproach
AT marikotaniguchiikeda unexpectedmutationsbycrisprcas9ctgrepeatexcisioninmyotonicdystrophyanduseofcrisprinterferenceasanalternativeapproach
AT takemakato unexpectedmutationsbycrisprcas9ctgrepeatexcisioninmyotonicdystrophyanduseofcrisprinterferenceasanalternativeapproach
AT yasukoshinkai unexpectedmutationsbycrisprcas9ctgrepeatexcisioninmyotonicdystrophyanduseofcrisprinterferenceasanalternativeapproach
AT sonokotanaka unexpectedmutationsbycrisprcas9ctgrepeatexcisioninmyotonicdystrophyanduseofcrisprinterferenceasanalternativeapproach
AT hirokihagiwara unexpectedmutationsbycrisprcas9ctgrepeatexcisioninmyotonicdystrophyanduseofcrisprinterferenceasanalternativeapproach
AT naomichisasaki unexpectedmutationsbycrisprcas9ctgrepeatexcisioninmyotonicdystrophyanduseofcrisprinterferenceasanalternativeapproach
AT toshihiromasaki unexpectedmutationsbycrisprcas9ctgrepeatexcisioninmyotonicdystrophyanduseofcrisprinterferenceasanalternativeapproach
AT kiichiromatsumura unexpectedmutationsbycrisprcas9ctgrepeatexcisioninmyotonicdystrophyanduseofcrisprinterferenceasanalternativeapproach
AT masahirosonoo unexpectedmutationsbycrisprcas9ctgrepeatexcisioninmyotonicdystrophyanduseofcrisprinterferenceasanalternativeapproach
AT hirokikurahashi unexpectedmutationsbycrisprcas9ctgrepeatexcisioninmyotonicdystrophyanduseofcrisprinterferenceasanalternativeapproach
AT fumiakisaito unexpectedmutationsbycrisprcas9ctgrepeatexcisioninmyotonicdystrophyanduseofcrisprinterferenceasanalternativeapproach